A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM)

NCT07331272 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus (SLE)
Idiopathic Inflammatory Myopathies(IIM)

Interventions

BIOLOGICAL: LUCAR-G79D T cells

Sponsor

Nanjing Legend Biotech Co.